Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology

The Journal of Allergy and Clinical Immunology

Volumn 93, Issue 1 PART 1, 1994, Pages 1-11

  Moser, Michel ^a   Crameri, Reto ^a   Brust, Erika ^a   Suter, Mark ^a   Menz, Günter ^a  

^a NONE

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergillus fumigatus allergy; ELISA; recombinant allergen; skin test

Indexed keywords

ALLERGEN; CORTICOSTEROID; HYBRID PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RIBOSOME RNA;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ANTIGEN BINDING; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHOPULMONARY ASPERGILLOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTRACUTANEOUS TEST; MALE; POLYMERASE CHAIN REACTION; PRICK TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; RADIOIMMUNOASSAY; SEROLOGY; SKIN TEST;

ADULT; ALLERGENS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ASTHMA; COMPARATIVE STUDY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMAN; HYPERSENSITIVITY; IMMUNOGLOBULIN ISOTYPES; MALE; MIDDLE AGE; PLANT EXTRACTS; RECOMBINANT PROTEINS; SEROLOGIC TESTS; SKIN TESTS; SUPPORT, NON-U.S. GOV'T;

EID: 0028008424     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(94)90227-5     Document Type: Article

References (47)

1. Allergic bronchopulmonary aspergillosis
2. The clinical spectrum of aspergillosis part 1-epidemiology pathogenicity infection in animals and immunology of Aspergillus
3. Allergic bronchopulmonary aspergillosis
4. Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis
5. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis
6. Aspergillus fumigatus specific IgE and IgG antibodies for diagnosis of Aspergillus-related lung diseases
7. Precipitins and specific IgG antibody to Aspergillus fumigatus in a chest unit population
8. A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London
9. An analysis of skin prick test reaction in 656 asthmatic patients
10. Skin tests used in type 1 allergy skin testing
11. Antigenic variability of different strains of Aspergillus fumigatus
12. Antigens and allergens of Aspergillus fumigatus. I. Characterization by quantitative immunoelectrophoretic techniques
13. Standardization of allergenic extracts of Aspergillus fumigatus: liberation of IgE-binding components during cultivation
14. The allergenic and antigenic properties of spore extracts of Aspergillus fumigatus: a comparative study of spore extracts with mycelium and culture filtrate extracts
15. Nucleotide sequence of a genomic and a cDNA clone encoding an extracellular alkaline protease of Aspergillus fumigatus
16. Isolation and characterisation of an extracellular alkaline protease of Aspergillus fumigatus
17. Enzyme profile and immunochemical characterization of Aspergillus fumigatus antigens
18. The histamine content of allergen extracts
19. Antigens of Aspergillus fumigatus. II. Electrophoretic and clinical studies
20. Antibodies against Aspergillus fumigatus. I. Standardization of the antigenic composition
21. Allergen standardization
22. Precision of biological standardization of allergenic preparations
23. Antigens and allergens of Aspergillus fumigatus. II. Their further identification and partial characterization of a major allergen (Ag 3)
24. IgG antibodies to purified Aspergillus fumigatus antigens determined by enzyme-linked immunosorbent assay
25. Recombinant allergens: biological, immunological and practical aspects
26. Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity
27. Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleolytic toxin restrictocin and its expression in Aspergillus nidulans: the leader sequence protects producing strains from suicide
28. Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus
29. Guidelines for the diagnosis and management of asthma
30. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis
31. Allergic bronchopulmonary aspergillosis: staging as an aid to management
32. System for high level production in E. coli and rapid purification of recombinant proteins: application to epitope mapping, preparation of antibodies and structure-function analysis
33. β-Galactosidase from termination and deletion mutant strains
34. The ribonuclease activity of the cytotoxin α-sarcin
35. Influence of the histamine control on skin reactivity in skin testing
36. The physical and functional behavior of capture antibodies adsorbed on polystyrene
37. Quantitation of specific antibodies: methods of expression, standards, solid-phase considerations, and specific applications
38. Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins
39. Characterization of immunologically important antigens and allergens of Aspergillus fumigatus
40. Skin tests in clinical practice and epidemiology
41. Viral infection permeabilizes mammalian cells to protein toxins
42. The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells
43. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
44. Immunosuppression in vitro by a metabolite of a human pathogenic fungus
45. Possible role of IgG4 in discordant correlations between intracutaneous skin tests and RAST
46. Discrepancies between the skin test and IgE antibody assays: study of histamine release, complement activation in vitro, and occurrence of allergen specific IgG